🔗 Share this article

Texas Attorney General Ken Paxton is suing the manufacturers of acetaminophen, claiming the firms concealed alleged dangers that the drug presented to pediatric cognitive development.

The court filing comes a month after Former President Trump promoted an unsubstantiated connection between consuming Tylenol - also known as acetaminophen - during pregnancy and autism spectrum disorder in young ones.

The attorney general is filing suit against J&J, which previously sold the drug, the exclusive pain medication suggested for pregnant women, and Kenvue, which now manufacturers it.

In a statement, he claimed they "deceived the public by gaining financially from discomfort and promoting medication regardless of the risks."

Kenvue says there is no credible evidence tying Tylenol to autism.

"These companies deceived for years, intentionally threatening millions to boost earnings," the attorney general, a Republican, declared.

The manufacturer stated officially that it was "very worried by the perpetuation of misinformation on the safety of paracetamol and the possible consequences that could have on the well-being of women and children in America."

On its online platform, the company also stated it had "consistently assessed the applicable studies and there is no credible data that shows a established connection between taking paracetamol and autism spectrum disorder."

Groups speaking for medical professionals and medical practitioners agree.

The American College of Obstetricians and Gynecologists has said acetaminophen - the main ingredient in Tylenol - is a restricted selection for women during pregnancy to treat discomfort and elevated temperature, which can pose serious health risks if ignored.

"In over twenty years of studies on the consumption of paracetamol in pregnancy, zero credible investigations has definitively established that the usage of paracetamol in any period of gestation leads to neurodevelopmental disorders in children," the group commented.

The lawsuit cites current declarations from the previous government in arguing the drug is reportedly hazardous.

Last month, Trump caused concern from medical authorities when he told expectant mothers to "fight like hell" not to consume Tylenol when ill.

Federal regulators then released a statement that medical professionals should contemplate reducing the usage of Tylenol, while also declaring that "a proven link" between the drug and autism in minors has not been established.

Health Secretary Kennedy, who supervises the Food and Drug Administration, had vowed in spring to undertake "comprehensive study program" that would identify the cause of autism in a short period.

But specialists advised that finding a sole reason of autism spectrum disorder - considered by experts to be the outcome of a complex mix of inherited and environmental factors - would be difficult.

Autism is a form of enduring cognitive variation and condition that influences how individuals encounter and relate to the environment, and is identified using physician assessments.

In his legal document, the attorney general - aligned with the former president who is running for US Senate - asserts Kenvue and J&J "willfully ignored and tried to quiet the science" around acetaminophen and autism spectrum disorder.

The case seeks to make the companies "destroy any promotional materials" that asserts acetaminophen is reliable for women during pregnancy.

The court case mirrors the grievances of a group of parents of young ones with autism spectrum disorder and attention deficit hyperactivity disorder who took legal action against the manufacturers of Tylenol in two years ago.

The court threw out the case, saying research from the family's specialists was inconclusive.